Lucideon invests in an Agilent 7900 Quadrapole ICP-MS to extend its analysis techniques offerings

Lucideon, the  international provider of materials development, testing and assurance, and formerly known as Ceram, is pleased to announce it has invested in the latest Agilent 7900 Quadrapole Inductively Coupled Plasma – Mass Spectrometry (ICP-MS).

The new ICP-MS identifies elements by their individual masses and isotopic fingerprints, and can achieve detection limits in the sub – parts per billion range. As well as isotopic identification, the new analytical equipment will allow Lucideon’s experts to do trace analysis of metals in a range of matrixes including pharmaceutical products, wear testing fluids, water, and validate the cleanliness of washed samples.

The new system analyses the majority of elements in the periodic table by ionising species to the +1 state, followed by Quadrapole Mass Spectrometry analysis of the ionised species. In addition, it is also able to distinguish between different oxidation states of elements and analyse anions and organic (carbon based) material.

Parmjit Bilan, Pharmaceutical Business and Technical Manager, commented:

“Our investment is further evidence of our commitment to offer a comprehensive testing and analysis service to our pharmaceutical and medical device clients. However, the ICP-MS can also be used for trace metal migration in food contact studies, nano-particle and nuclear applications. Oils, diesels and organic solvents can also be analysed directly on the instrument.

“The ICP-MS also allows us to offer isotope dilution analysis, meaning that we will be able to analyse archaeological, blood, hair and plant samples.”

To find out more about the analysis capabilities of the new Agilent 7900 Quadrapole ICP-MS, visit https://www.lucideon.com/.

About Lucideon

Lucideon is a leading international provider of materials development, testing and assurance.

Through its offices and laboratories in the UK, US and the Far East, Lucideon provides materials and assurance expertise to clients in a wide range of sectors, including healthcare, construction, ceramics and power engineering.

The company aims to improve the competitive advantage and profitability of its clients by providing them with the expertise, accurate results and objective, innovative thinking that they need to optimise their materials, products, processes, systems and businesses.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Lucideon. (2023, March 22). Lucideon invests in an Agilent 7900 Quadrapole ICP-MS to extend its analysis techniques offerings. News-Medical. Retrieved on November 23, 2024 from https://www.news-medical.net/news/20140521/Lucideon-invests-in-an-Agilent-7900-Quadrapole-ICP-MS-to-extend-its-analysis-techniques-offerings.aspx.

  • MLA

    Lucideon. "Lucideon invests in an Agilent 7900 Quadrapole ICP-MS to extend its analysis techniques offerings". News-Medical. 23 November 2024. <https://www.news-medical.net/news/20140521/Lucideon-invests-in-an-Agilent-7900-Quadrapole-ICP-MS-to-extend-its-analysis-techniques-offerings.aspx>.

  • Chicago

    Lucideon. "Lucideon invests in an Agilent 7900 Quadrapole ICP-MS to extend its analysis techniques offerings". News-Medical. https://www.news-medical.net/news/20140521/Lucideon-invests-in-an-Agilent-7900-Quadrapole-ICP-MS-to-extend-its-analysis-techniques-offerings.aspx. (accessed November 23, 2024).

  • Harvard

    Lucideon. 2023. Lucideon invests in an Agilent 7900 Quadrapole ICP-MS to extend its analysis techniques offerings. News-Medical, viewed 23 November 2024, https://www.news-medical.net/news/20140521/Lucideon-invests-in-an-Agilent-7900-Quadrapole-ICP-MS-to-extend-its-analysis-techniques-offerings.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New knee and hip wear testing white paper released by Lucideon